Health Condition 1: H350- Background retinopathy and retinalvascular changes
Conditions
Interventions
Intervention1: Vasakadi Ghan Vati along with Standard Anti-Hypertensive: Ghan formed by Kwatha of herbs (Adathoda vasica , Terminalia chebula , Azardirachta indica , Embilica officinalis , Cyperus rot
Sponsors
R A Podar Medical Ayurvedic College
Eligibility
Inclusion criteria
Inclusion criteria: 1)Willing to give written consent to participate in the study. 2)Age 20-70 years. 3)Both sexes. 4)Known patient of essential hypertension presenting signs of hypertensive retinopathy on fundal examination. 5)Subject with hypertensive retinopathy: Keith Wegner Barker Grade 1, 2 and 3. 6)Subject with systolic blood pressure less than 180 mm of Hg. and diastolic blood pressure less than 120 mm of Hg. 7)Hypertensive patient complaining of dimness of vision.
Exclusion criteria
Exclusion criteria: 1)Age less than 20 years and more than 70 years. 2)Secondary hypertension and Severe or stage • hypertension (Blood pressure more than equal to 180/110 mm of Hg.) 3)Presence of fundus alteration which did not result from arterial hypertension. 4)Presence of cardio-vascular disease other than hypertension and collagen disease. 5)Presence of hypertensive emergencies and urgencies (diastolic blood pressure more than equal to 130 mm of Hg. or severe blood pressure with target organ damage.)and hypertension related disorders. 6)Diabetes mellitus. 7)Thyroid disease. 8)Current abuse of alcohol or other drug. 9)Mental incapacitance. 10)Unwillingness. 11)Dropouts.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To see the effect of Vasakadi Ghan Vati in arteriosclerotic changes , exudates and haemorrhages seen in hypertensive retinopathy.Timepoint: 1. To see the effect of Vasakadi Ghan Vati in arteriosclerotic changes , exudates and haemorrhages seen in hypertensive retinopathy by the end of 3 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To stabilise or improve visual acuity lost due to hypertensive retinopathy. 2. To study the changes in the bio-chemical parameters in the patients with hypertensive retinopathy after administration of Vasakadi Ghan Vati for three months. 3. To study adverse and safety events related with Vasakadi Ghan Vati. Timepoint: End of 3 Months | — |
Countries
India
Contacts
Public ContactDr Sukhada Kulkarni
R.A.Podar Med(Ayu) College , Worli , Mumbai
Outcome results
None listed